11-halo prostaglandins for the treatment of glaucoma or ocular hypertension
US6353000B1 · kind B1 · utility
6Cited by
0References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 2, 1999 |
| Grant date | Mar 5, 2002 |
| Priority date | — |
| Expiry date | Jun 2, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C405/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating glaucoma or ocular hypertension in a patient, which comprises administering to the patient a pharmaceutically effective amount of a compound of formula I:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.